Clinical trial
Impact of the Reimbursement of Fibrinogen on Transfusion, Mortality and Morbidity in Cardiac Surgery
NCT07457879 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the Reimbursement of Fibrinogen on Transfusion, Mortality and Morbidity in Cardiac Surgery
- Lead sponsor
- Erasme University Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 20, 2026
- Completion date
- June 10, 2026
- Enrollment
- 450 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac surgery